{"id":34973,"date":"2025-03-23T21:00:00","date_gmt":"2025-03-23T21:00:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/4647263_AE47263_0"},"modified":"2025-03-23T21:00:00","modified_gmt":"2025-03-23T21:00:00","slug":"volpara-health-announces-boadicea-integration-and-record-ecr-2025-research-presence","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=34973","title":{"rendered":"Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence"},"content":{"rendered":"<table name=\"logo_release\" border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/389465\/Volpara_Health_Logo.jpg?p=medium600\" border=\"0\" alt title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">CANBERRA, Australia<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">March 24, 2025<\/span><\/span> \/PRNewswire\/ &#8212;&nbsp;Volpara Health, a global leader in AI-powered breast health solutions and a subsidiary of Lunit, today announced two major milestones:<\/p>\n<ul type=\"disc\">\n<li>Volpara density is now a validated input to the BOADICEA breast cancer risk model.<\/li>\n<li>A record of 21 independent abstracts featuring Lunit and Volpara solutions were presented at ECR 2025.<\/li>\n<\/ul>\n<p><b>Volpara density now integrated into BOADICEA breast cancer risk model<\/b><\/p>\n<p>Volpara volumetric breast density assessment is now a validated input to the newly released version of the BOADICEA breast cancer risk model. This marks a significant milestone, as Volpara density is now integrated into two different breast cancer risk models\u2014Tyrer-Cuzick and BOADICEA, sometimes referred to as IBIS or CanRisk, respectively.<\/p>\n<p>Any Volpara customers can use their Volpara density information via CanRisk today. CanRisk is endorsed by international societies and guidelines for use in <span class=\"xn-location\">Australia<\/span>, the EU, the UK, the US, and <span class=\"xn-location\">Canada<\/span>. Studies have shown the use of Volpara density in BOADICEA to improve model accuracy compared to using BI-RADS density categories, enhancing breast cancer risk assessment capabilities for healthcare providers worldwide.<\/p>\n<p><b>A record-high 21 Lunit and Volpara research abstracts at ECR 2025<\/b><\/p>\n<p>At the European Congress of Radiology (ECR) 2025, Lunit and Volpara&#8217;s solutions were featured in a record-high 21 independent research abstracts. This milestone highlights the growing impact of AI-driven breast health solutions in the global radiology community, reinforcing Volpara&#8217;s and Lunit&#8217;s commitment to advancing cancer detection and patient care through innovation and scientific research.<\/p>\n<p><b>About Volpara Health<\/b><\/p>\n<p>Volpara Health is on a mission to save families from cancer with AI-powered software that helps healthcare providers better understand cancer risk, guide personalized care decisions, and recommend additional imaging and interventions. Used in over 3,500 facilities by more than 9,500 technologists worldwide. Volpara&#8217;s software impacts nearly <span class=\"xn-money\">18M<\/span> patients, supports over <span class=\"xn-money\">3.6M<\/span> annual cancer risk assessments, and integrates seamlessly with electronic health records and imaging systems. Volpara helps radiologists quantify dense breast tissue with precision and technologists produce mammograms with optimal positioning, compression, and dose. Volpara software also streamlines operations to ease compliance and accreditation. Volpara, a Lunit company, is headquartered in <span class=\"xn-location\">Wellington, New Zealand<\/span>, and has an office in <span class=\"xn-location\">Seattle<\/span>. Volpara is the trusted partner of leading healthcare institutions globally. For more information, visit <u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4388982-1&amp;h=2774954657&amp;u=http%3A%2F%2Fwww.volparahealth.com%2F&amp;a=www.volparahealth.com\" target=\"_blank\" rel=\"nofollow noopener\">www.volparahealth.com<\/a><\/u>.<\/p>\n<p><b>Volpara Media Contact:&nbsp;<br \/><\/b><span class=\"xn-person\">Andrew Thompson-Young<\/span><br \/>Clarity Quest <br \/><u><a href=\"mailto:Andrew@Clarityqst.com\" target=\"_blank\" rel=\"nofollow noopener\">Andrew@Clarityqst.com<\/a><br \/><\/u>615-784-3103<\/p>\n<p>Logo &#8211; <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4388982-1&amp;h=1051663641&amp;u=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F389465%2FVolpara_Health_Logo.jpg&amp;a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F389465%2FVolpara_Health_Logo.jpg\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/mma.prnasia.com\/media2\/389465\/Volpara_Health_Logo.jpg?p=medium600<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>CANBERRA, Australia, March 24, 2025 \/PRNewswire\/ &#8212;&nbsp;Volpara Health, a global leader in AI-powered breast health solutions and a subsidiary of Lunit, today announced two major milestones: Volpara density is now a validated input to the BOADICEA breast cancer risk model. A record of 21 independent abstracts featuring Lunit and Volpara solutions were presented at ECR [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-34973","post","type-post","status-publish","format-standard","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=34973\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence - My Blog\" \/>\n<meta property=\"og:description\" content=\"CANBERRA, Australia, March 24, 2025 \/PRNewswire\/ &#8212;&nbsp;Volpara Health, a global leader in AI-powered breast health solutions and a subsidiary of Lunit, today announced two major milestones: Volpara density is now a validated input to the BOADICEA breast cancer risk model. A record of 21 independent abstracts featuring Lunit and Volpara solutions were presented at ECR [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=34973\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-23T21:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnasia.com\/media2\/389465\/Volpara_Health_Logo.jpg?p=medium600\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=34973#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=34973\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence\",\"datePublished\":\"2025-03-23T21:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=34973\"},\"wordCount\":403,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=34973#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/389465\\\/Volpara_Health_Logo.jpg?p=medium600\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=34973\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=34973\",\"name\":\"Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=34973#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=34973#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/389465\\\/Volpara_Health_Logo.jpg?p=medium600\",\"datePublished\":\"2025-03-23T21:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=34973#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=34973\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=34973#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/389465\\\/Volpara_Health_Logo.jpg?p=medium600\",\"contentUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/389465\\\/Volpara_Health_Logo.jpg?p=medium600\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=34973#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=34973","og_locale":"en_US","og_type":"article","og_title":"Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence - My Blog","og_description":"CANBERRA, Australia, March 24, 2025 \/PRNewswire\/ &#8212;&nbsp;Volpara Health, a global leader in AI-powered breast health solutions and a subsidiary of Lunit, today announced two major milestones: Volpara density is now a validated input to the BOADICEA breast cancer risk model. A record of 21 independent abstracts featuring Lunit and Volpara solutions were presented at ECR [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=34973","og_site_name":"My Blog","article_published_time":"2025-03-23T21:00:00+00:00","og_image":[{"url":"https:\/\/mma.prnasia.com\/media2\/389465\/Volpara_Health_Logo.jpg?p=medium600","type":"","width":"","height":""}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=34973#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=34973"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence","datePublished":"2025-03-23T21:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=34973"},"wordCount":403,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=34973#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnasia.com\/media2\/389465\/Volpara_Health_Logo.jpg?p=medium600","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=34973","url":"https:\/\/transmediavictoria.net.au\/?p=34973","name":"Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=34973#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=34973#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnasia.com\/media2\/389465\/Volpara_Health_Logo.jpg?p=medium600","datePublished":"2025-03-23T21:00:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=34973#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=34973"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=34973#primaryimage","url":"https:\/\/mma.prnasia.com\/media2\/389465\/Volpara_Health_Logo.jpg?p=medium600","contentUrl":"https:\/\/mma.prnasia.com\/media2\/389465\/Volpara_Health_Logo.jpg?p=medium600"},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=34973#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/34973","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=34973"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/34973\/revisions"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=34973"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=34973"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=34973"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}